258 related articles for article (PubMed ID: 27492945)
1. Medical Decision Making: Hyposphagma Prior to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
Newey CR; Cueva W; Vellipuram A; Hornik A
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e181-2. PubMed ID: 27492945
[TBL] [Abstract][Full Text] [Related]
2. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
[TBL] [Abstract][Full Text] [Related]
3. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
4. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
[TBL] [Abstract][Full Text] [Related]
5. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
[TBL] [Abstract][Full Text] [Related]
7. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
[TBL] [Abstract][Full Text] [Related]
8. Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.
Chou C; Bourekas EC; Slivka A
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1823-1827. PubMed ID: 27133771
[TBL] [Abstract][Full Text] [Related]
9. Downstream Migration and Fragmentation of a Spontaneous Calcific Embolus after Thrombolysis in a Patient with Ischemic Stroke.
López-Cuevas R; Lago A; Tembl JI
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e165-6. PubMed ID: 27499273
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
11. Incidental Thrombotic Thrombocytopenic Purpura during Acute Ischemic Stroke and Thrombolytic Treatment.
Acır İ; Erdoğan HA; Yayla V; Taşdemir N; Çabalar M
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1417-1419. PubMed ID: 29196200
[TBL] [Abstract][Full Text] [Related]
12. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?
Barrett KM; Gottesman RF
Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635
[No Abstract] [Full Text] [Related]
13. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
Edwards NJ; Kamel H; Josephson SA
Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
15. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
16. Isolated Sulcal Effacement and Response to Intravenous Thrombolysis in Acute Ischemic Stroke.
Pektezel MY; Arsava EM; Gocmen R; Topcuoglu MA
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105168. PubMed ID: 32912520
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
Agrawal K; Raman R; Ernstrom K; Claycomb RJ; Meyer DM; Hemmen TM; Modir RF; Kachhi P; Meyer BC
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
[TBL] [Abstract][Full Text] [Related]
19. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
20. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
